Form 4: I-Mab Executive Sells Shares
Insider Transaction (Form 4)
Phillip Andrew Dennis, Chief Medical Officer of I-Mab, sold 8,209 shares of common stock on September 17, 2026 for $0.71 per share.
Summary
- Option exercise/conversion: acquired 23,695 Ordinary Shares on September 17, 2026; holds 181,636 after (Direct).
- Open-market sale: disposed of 8,209 Ordinary Shares at $0.71 ($5,828) on September 18, 2026; holds 173,427 after (Direct).
- Option exercise/conversion: disposed of 10,302 Restricted Share Units on September 17, 2026; holds 72,120 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $5,828 of stock on the open market.
Insider Transactions
Phillip Andrew Dennis — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-17 | Option exercise/conversion | Ordinary Shares | 23,695 | — | — | 181,636 |
| 2026-09-18 | Open-market sale | Ordinary Shares | 8,209 | $1 | $5.8K | 173,427 |
| 2026-09-17 | Option exercise/conversion | Restricted Share Units | 10,302 | — | — | 72,120 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-17 | Option exercise/conversion (23,695 shares) |
| 2026-09-18 | Open-market sale (8,209 shares) |
| 2026-09-17 | Option exercise/conversion (10,302 shares) |
Keywords
insider transaction, Form 4, NBP, NovaBridge Biosciences, bearish, Phillip Andrew Dennis
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.